Alan D. Robertson - Concepedia

Author

Alan D. Robertson

Also Known As

A D Robertson, A. D. ROBERTSON, A.D. Robertson, Alan D Robertson, Alan D. Robertson, Alan Robertson, Patrick M. Woollard, Robertson, Alan, Robertson, Alan D.

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Monash University Wellcome Trust The University of Melbourne University of Glasgow Ninewells Hospital

About

Alan D. Robertson is an author at Monash University specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	1.5K
2	Natural Sciences	6	6	226
3	Engineering	3	3	90
4	Health Sciences	1	1	179
5	Humanities	1	1	73

Alan D. Robertson

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
PI 3-kinase p110β: a new target for antithrombotic therapy Shaun P. Jackson, Simone M. Schoenwaelder, Isaac Goncalves, Nature Medicine ThrombosisMedicinePi 3-Kinase P110βPharmacotherapyPharmacology	2005	588
The classification of prostaglandin DP‐receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist Heather Giles, P. Leff, Mary L. Bolofo, British Journal of Pharmacology PharmacotherapyPlatelet AggregationExperimental PharmacologyPotent Competitive AntagonistInflammation	1989	195
The novel N-type calcium channel blocker, AM336, produces potent dose-dependent antinociception after intrathecal dosing in rats and inhibits substance P release in rat spinal cord slices Maree T. Smith, Peter J. Cabot, F. B. Ross, Pain Pain MedicineNeuropathic PainMolecular PainPharmacotherapyExperimental Pharmacology	2002	179
Receptor specificity and trigemino‐vascular inhibitory actions of a novel 5‐HT<sub>1B/1D</sub> receptor partial agonist, 311C90 (zolmitriptan) Graeme R. Martin, Alan D. Robertson, Sara MacLennan, British Journal of Pharmacology PharmacotherapyExperimental PharmacologyMolecular PharmacologyMedicinal ChemistryPharmacological Study	1997	101
Some features of the autoxidation of tetralin Alan D. Robertson, William A. Waters Transactions of the Faraday Society HumanitiesMedicineMechanism Of ActionNeuropharmacologyPharmacotherapy	1946	73
Cardiovascular and autonomic effects of ω‐conotoxins MVIIA and CVID in conscious rabbits and isolated tissue assays Christine E. Wright, Alan D. Robertson, Sarah L. Whorlow, British Journal of Pharmacology	2000	53
Dynamic Palmitoylation of the Sodium-Calcium Exchanger Modulates Its Structure, Affinity for Lipid-Ordered Domains, and Inhibition by XIP Çağlar Gök, Fiona Plain, Alan D. Robertson, Cell Reports Proteinlipid InteractionSodium-calcium Exchanger ModulatesMolecular BiologyControls Ncx1 InactivationLipid Movement	2020	53
The antagonism by BW A868C of PGD<sub>2</sub> and BW245C activation of human platelet adenylate cyclase David G. Trist, Brian Collins, John R. Wood, British Journal of Pharmacology Molecular BiologyPlatelet PathobiologyExperimental PharmacologyMolecular PharmacologyRectangular Hyperbola	1989	48
317. Studies of the autoxidation of tetralin. Part I. Investigation of autoxidation products Alan D. Robertson, William A. Waters Journal of the Chemical Society (Resumed) A. RobertsonChemistrySpectra-structure CorrelationStructure ElucidationAutoxidation Products	1948	41
Recovery of experimental Parkinson's disease with the melatonin analogues ML-23 and S-20928 in a chronic, bilateral 6-OHDA model: a new mechanism involving antagonism of the melatonin receptor Gregory L. Willis, Alan D. Robertson Pharmacology Biochemistry and Behavior NeurophysiologyMedicineFunctional SelectivityPhysiologyNew Mechanism	2004	39

Page 1